Triple-negative breast cancer: what is known about it?
Triple-negative breast cancer (TNBC) is considered a rare diagnosis. This malignancy targets a specific population of women and has risk factors differing from those of other breast cancers. TNBC exhibits distinct pathologic features that result in aggressive metastasis and poor prognosis. Pathologically, TNBC cancer cells are characterized by negative receptors for progesterone and estrogen and by the lack of over-expression of human epidermal growth factor receptor 2, which limits chemotherapeutic treatment options for women with TNBC. Nurses can assist in early detection by offering patient education about the little known risk factors for TNBC. Psychosocial issues can overwhelm patients diagnosed with breast cancer. This article provides suggestions for nurses as they guide women who are experiencing an atypical breast cancer diagnosis with an uncertain prognosis and limited treatment options.
Houston J. and Florence A. Dowswell College of Nursing, Texas Woman's University in Dallas.
Lisa L
LL
Ferguson
Houston J. and Florence A. Dowswell College of Nursing, Texas Woman's University in Dallas.
Britne
B
Curran
Houston J. and Florence A. Dowswell College of Nursing, Texas Woman's University in Dallas.
Mary
M
Martinez
Houston J. and Florence A. Dowswell College of Nursing, Texas Woman's University in Dallas.
Peggy
P
Mancuso
D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008875:Middle Aged; D010353:Patient Education as Topic; D011379:Prognosis; D012307:Risk Factors; D016896:Treatment Outcome; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000503:physiopathology* / Q000523:psychology
breast cancer; chemotherapy; patient/public education; psychosocial aspects; surgery